drugset
drugset / Trial / NCT00041561

Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics

NCT00041561 ↗

Phase 3 Terminated 55 enrolled Mallinckrodt
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the effect of nitric oxide for inhalation on the duration of mechanical ventilation in pediatric patients with AHRF.

Timeline

Start
2002-01
Primary completion
2004-12
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 5 ppm Inhaled

Indications

acute respiratory failure